Tech Company Inital Public Offerings

Kinnate Biopharma IPO

Based in San Diego, Kinnate Biopharma is now a public company.

Transaction Overview

Company Name
Announced On
Transaction Type
Proceeds Purpose
Per the firm's most recent regulatory filing, it plans to use the net proceeds as follows:approximately $105.0 million to fund the continued development of our RAF program, including our most advanced product candidate, KIN002787;approximately $35.0 million to fund the continued development of product candidates in our FGFR program; andthe remaining amounts, if any, to fund the continued development of our other research programs, as well as for working capital and other general corporate purposes.

Company Information

Company Status
Mailing Address
11975 El Camino Real 101
San Diego, CA 92130
Email Address
Not Recorded
Kinnate Biopharma (Nasdaq: KNTE) is a biopharmaceutical company advancing a pipeline of precision oncology therapeutics to treat patients with genomically defined vulnerabilities.
Kinnate Biopharma LinkedIn Company Profile
Social Media
Kinnate Biopharma Company Twitter Account
Company News
Kinnate Biopharma News
Kinnate Biopharma on Facebook
Kinnate Biopharma on YouTube

Management Team

Email & Social
Chief Executive Officer
Nima Farzan
  Nima Farzan LinkedIn Profile  Nima Farzan Twitter Account  Nima Farzan News  Nima Farzan on Facebook
Chief Medical Officer
Richard Williams
  Richard Williams LinkedIn Profile  Richard Williams Twitter Account  Richard Williams News  Richard Williams on Facebook
Chief Operating Officer
Mark Meltz
  Mark Meltz LinkedIn Profile  Mark Meltz Twitter Account  Mark Meltz News  Mark Meltz on Facebook
Chief Scientific Officer
Eric Murphy
  Eric Murphy LinkedIn Profile  Eric Murphy Twitter Account  Eric Murphy News  Eric Murphy on Facebook
Vice President
Robert Kania
  Robert Kania LinkedIn Profile  Robert Kania Twitter Account  Robert Kania News  Robert Kania on Facebook
Vice President
Eric Martin
  Eric Martin LinkedIn Profile  Eric Martin Twitter Account  Eric Martin News  Eric Martin on Facebook
Vice President
Sanjeev Thohan
  Sanjeev Thohan LinkedIn Profile  Sanjeev Thohan Twitter Account  Sanjeev Thohan News  Sanjeev Thohan on Facebook



Browse more venture capital transactions:

Prev: 12/2/2020: Infogrid venture capital transaction
Next: 12/2/2020: Tallac Therapeutics venture capital transaction


Share this article


Where The Data Comes From

Our team works diligently to report on all VC transactions involving tech companies. All VC database entries reported here are derived from company press releases and news coverage. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary